Should more MDS patients be treated with immune-suppression?
Leuk Res
.
2018 Aug:71:25-26.
doi: 10.1016/j.leukres.2018.06.011.
Epub 2018 Jun 19.
Author
Antonio Almeida
1
Affiliation
1
Serviço de Hematologia, Hospital da Luz Lisboa, Lisbon, Portugal. Electronic address: amalmeida@hospitaldaluz.pt.
PMID:
29936306
DOI:
10.1016/j.leukres.2018.06.011
No abstract available
Keywords:
Immune suppression; MDS.
Publication types
Comment
MeSH terms
Antilymphocyte Serum*
Cyclosporine
DNA Mutational Analysis
Humans
Immunosuppression Therapy
Myelodysplastic Syndromes*
Substances
Antilymphocyte Serum
Cyclosporine